Molecular Testing for MRSA and C. diff.: Using New Tools to Identify and Reduce HAIs
15 Nov 2012

For both economic and regulatory reasons, hospitals and other healthcare facilities are stepping up efforts to decrease healthcare-associated infection (HAI) rates. Clinical labs can be helpful in these initiatives, particularly in identifying methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff.) infections. This webinar discusses the new technologies that detect these pathogens more quickly and accurately than ever before, and how labs are incorporating them into their testing strategies and surveillance programs.

AACC



Show    per page
1 of 10 Page     1 2 3  ... Next 
A New Concept in Metabolic Studies: How Personalized 'Sportomics' Bridges Bench and Clinical Science24 Jul 2014Read
Process development and optimisation using ambr250™ for mammalian and microbial processes2 Jul 2014Read
Why does ice cream taste smooth or gritty? It depends on the rheology!30 Jun 2014Read
Masterclass 4: Configuring optical parameters for laser diffraction particle size analysis30 Jun 2014Read
The Science of Beauty - Characterizing Hyaluronic Acid - the molecule behind anti-aging creams30 Jun 2014Read
Polymer solution characterization part 3: Branching out! Intrinsically useful views on polymer structure30 Jun 2014Read
Optical Properties of Organic Compounds: obtaining the refractive index and absorption values for use in laser diffraction particle size analysis30 Jun 2014Read
Configuring optical parameters for laser diffraction particle size analysis19 Jun 2014Read
Click Chemistry Reagents Labeled with DBCO Groups Allow for Copper-Free Biomolecule Labeling Reactions18 Jun 2014Read
In-Vivo Two-Photon Imaging of the Diseased Nervous System18 Jun 2014Read